Surface Oncology ROCE Ratio 2011-2026 | SURF

Annual ROCE Ratio Surface Oncology

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-66.24	-63.93	39.54	-51.03	-6.23	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
39.54	-66.24	-29.58

Quarterly ROCE Ratio Surface Oncology

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-118.66	-86.11	-35.23	-50.09	-44.65	-37.62	-36.56	7.08	12.72	15.93	39.54	-32.92	-54.68	-78.01	-101.24	-77.84	-64.39	-47.84	-8.9	21.24	59.97	85.79	68.32	43.61	22.41	12.71	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
85.79	-118.66	-18.67

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
Compugen Ltd. CGEN	23.38	$ 2.86	3.62 %	$ 267 M	Israel
FSD Pharma HUGE	-299.89	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Enlivex Therapeutics Ltd. ENLV	-0.65	$ 0.8	-3.59 %	$ 36.6 M	Israel
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-368.0	-	-	$ 269 M	USA
Exelixis EXEL	40.35	$ 46.21	-5.11 %	$ 12.5 B	USA
Fortress Biotech FBIO	-140.8	$ 2.4	-5.88 %	$ 67 M	USA
BioNTech SE BNTX	-4.81	$ 93.02	-2.35 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Forte Biosciences FBRX	-115.85	$ 26.17	-1.32 %	$ 339 M	USA
Checkmate Pharmaceuticals CMPI	-88.5	-	-	$ 231 M	USA
ACADIA Pharmaceuticals ACAD	31.5	$ 22.56	5.03 %	$ 3.74 B	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	-19.96	$ 3.14	-0.32 %	$ 653 M	USA
Can-Fite BioPharma Ltd. CANF	-146.69	$ 3.54	3.51 %	$ 5.83 M	Israel
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
Genprex GNPX	-194.87	$ 0.87	-2.84 %	$ 811 K	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Allakos ALLK	-116.14	-	-	$ 28.6 M	USA
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	-6.45	$ 20.66	-14.52 %	$ 2.63 B	USA
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
Genmab A/S GMAB	31.74	$ 27.06	-2.98 %	$ 16.7 B	Danmark
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	-299.27	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	394.73	-	-	$ 8.42 M	USA
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	123.77	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	-34.58	$ 52.42	-4.83 %	$ 4.71 B	Schweiz
Avenue Therapeutics ATXI	-168.29	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-151.88	$ 1.61	-5.29 %	$ 428 M	Britain
Heron Therapeutics HRTX	-17.71	$ 1.24	-5.34 %	$ 207 M	USA
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA